The only free news source for serious moves across finance
Latest news tagged with #healthcare
Medline Inc.
Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range, according to people familiar with the matter, in what could be the year’s biggest listing.
UIPath, a robotics automation software company, has seen its shares rise close to 40% this year due in large part to the company's large customer base over several industries, spanning from healthcare to the US government.
UIPath, a robotics automation software company, has seen its shares rise close to 40% this year due in large part to the company's large customer base over several industries, spanning from healthcare to the US government. CFO & COO Ashim Gupta joined Carol Massar, Tim Stenovec, and Nina Trentmann on 'Bloomberg businessweek Daily' to discuss AI and automation trends. (Source: Bloomberg)
D.A. Wallach Explains Why Biotech VC Is So Different
The US Senate rejected Democratic and Republican healthcare plans to address the expiring Affordable Care Act subsidies.
The US Senate rejected Democratic and Republican healthcare plans to address the expiring Affordable Care Act subsidies. Representative Gregory Meeks (D-NY) joins Joe Mathieu on 'Bloomberg: Balance of Power' to discuss the ramifications it could bring to millions of Americans who get their health insurance through the Affordable Care Act. (Source: Bloomberg)
"Balance of Power: Late Edition" focuses on the intersection of politics and global business.
"Balance of Power: Late Edition" focuses on the intersection of politics and global business. On today's show, Democratic Representative of New York, Gregory Meeks, talks about the Senate rejecting both parties' healthcare plans and the ramifications it could bring to nearly 20 million Americans who rely on the Affordable Care Act for health insurance, and Rachel VanLandingham, Southwestern Law School Professor and former JAG Officer, discusses the legality of the US seizing a Venezuelan Oil...
Republican and Democratic lawmakers could not advance a pair of stopgap plans in the Senate that would address the expiring Obamacare subsidies.
Republican and Democratic lawmakers could not advance a pair of stopgap plans in the Senate that would address the expiring Obamacare subsidies
Republican and Democratic lawmakers seem poised to not advance a pair of stopgap plans in the Senate that would address the expiring Obamacare subsidies.
Republican and Democratic lawmakers seem poised to not advance a pair of stopgap plans in the Senate that would address the expiring Obamacare subsidies
The healthcare sector of the U.
The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull market.
Trial results are a boost to US pharmaceutical company’s booming obesity business.
Trial results are a boost to US pharmaceutical company’s booming obesity business
Trial results mark boost to US pharmaceutical company’s booming obesity business.
Trial results mark boost to US pharmaceutical company’s booming obesity business
Coeptis Therapeutics Holdings, Inc. has entered into a definitive merger agreement that will significantly bolster its position in the biopharmaceutical sector. This strategic move aims to accelerate growth and enhance product development capabilities, positioning Coeptis for future success.
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) has announced a definitive merger agreement as part of its strategic plan to enhance its capabilities within the biopharmaceutical industry. The merger is expected to create a more robust organization, positioning Coeptis to better serve its shareholders and enhance its product offerings. The merger involves the acquisition of Coeptis Therapeutics by an undisclosed partner, which is designed to leverage synergies between the two companies. While the specific financial terms...
Novo Nordisk A/S shares have fallen so much this year that it’s almost as if the frenzy around weight-loss drugs that propelled the Danish pharmaceutical company’s meteoric rise never happened.
Novo Nordisk A/S shares have fallen so much this year that it’s almost as if the frenzy around weight-loss drugs that propelled the Danish pharmaceutical company’s meteoric rise never happened.
Coeptis Therapeutics Holdings, Inc. has entered into a merger agreement with an undisclosed company, aiming to bolster its position in the biotech sector. This strategic move is expected to create synergies, enhance product offerings, and expand market reach.
In a significant development within the biotechnology sector, Coeptis Therapeutics Holdings, Inc. (Ticker: COEP) has announced a merger agreement aimed at strengthening its position in the market. This decision comes as part of Coeptis' strategy to enhance its product pipeline and expand its operational capabilities. ### Transaction Details The merger agreement, detailed in Coeptis' recent S-4/A SEC filing, outlines the terms of the transaction and highlights its strategic implications. While specific financial figures and exchange...
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich pharmaceutical companies.
Biotechs are instead spending their time advancing the kind of smart science that will catch the eye of cash-rich pharmaceutical companies.
Health insurers increasingly employ the doctors who provide the medical care they pay for, creating a conflict of interest.
Health insurers increasingly employ the doctors who provide the medical care they pay for, creating a conflict of interest.
To guarantee Americans the medication they need, the U.
To guarantee Americans the medication they need, the U.S. must stop relying on China and India.
Health insurers increasingly employ the doctors who provide the medical care they pay for, creating a conflict of interest.
Health insurers increasingly employ the doctors who provide the medical care they pay for, creating a conflict of interest.
To guarantee Americans the medication they need, the U.
To guarantee Americans the medication they need, the U.S. must stop relying on China and India.
Wave of M&A fuels rally as big pharma groups hunt for blockbusters ahead of patent cliff.
Wave of M&A fuels rally as big pharma groups hunt for blockbusters ahead of patent cliff
Senator Tina Smith (D-MN) discusses what next steps are for healthcare reform as the possibility both Democratic & Republican health care proposals may not have the votes to pass.
Senator Tina Smith (D-MN) discusses what next steps are for healthcare reform as the possibility both Democratic & Republican health care proposals may not have the votes to pass. She also talks about President Trump's healthcare plan and why she doesn't support it & voices her frustration with the President calling affordability a Democratic con job. Senator Smith speaks with Joe Mathieu on the late edition of Bloomberg's "Balance Of Power." (Source: Bloomberg)